AbbVie (ABBV) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free ABBV Stock Alerts $161.24 +4.93 (+3.15%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 1:51 PM | marketbeat.comBank of Nova Scotia Purchases 118,379 Shares of AbbVie Inc. (NYSE:ABBV)Bank of Nova Scotia increased its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 11.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,118,303 shares of the company's stock after purchasiJune 1 at 2:28 AM | americanbankingnews.comAbbVie Inc. (NYSE:ABBV) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMay 31 at 11:30 PM | marketbeat.comHarvest Investment Services LLC Takes Position in AbbVie Inc. (NYSE:ABBV)Harvest Investment Services LLC acquired a new position in AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 8,302 shares of the company's stock, valued at approximately $1,287,000. OMay 31 at 2:42 PM | marketbeat.comAbbVie (NYSE:ABBV) Shares Up 1.1%AbbVie (NYSE:ABBV) Stock Price Up 1.1%May 31 at 7:00 AM | marketbeat.com2 Generic Drug Makers With Growing Runways (ABBV)Brand name drug costs continue to climb but patients and insurers find respite by migrating to generic or biosimilar versions as patents run out.May 31 at 2:02 AM | prnewswire.comAbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderately to Severely Active Ulcerative ColitisMay 31 at 1:26 AM | americanbankingnews.comZacks Research Research Analysts Lower Earnings Estimates for AbbVie Inc. (NYSE:ABBV)May 30 at 6:39 PM | marketbeat.comTFO Wealth Partners LLC Has $14.89 Million Position in AbbVie Inc. (NYSE:ABBV)TFO Wealth Partners LLC increased its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 87,272.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,611 shares of the company's stock after acquiring an additiMay 30 at 1:45 PM | marketbeat.comAbbVie (NYSE:ABBV) Trading Up 0.5%AbbVie (NYSE:ABBV) Trading 0.5% HigherMay 30 at 12:00 PM | seekingalpha.comAbbVie: Turnaround Lurking After The Correction Pain (Upgrade)May 30 at 7:15 AM | seekingalpha.comAbbVie: This Dividend Aristocrat Is Almost Buyable Again NowMay 30 at 5:45 AM | fool.com3 Dividend Stocks to Double Up on Right NowMay 30 at 5:41 AM | marketbeat.comQ2 2024 EPS Estimates for AbbVie Inc. Lowered by Analyst (NYSE:ABBV)AbbVie Inc. (NYSE:ABBV - Free Report) - Research analysts at Zacks Research lowered their Q2 2024 EPS estimates for shares of AbbVie in a report released on Monday, May 27th. Zacks Research analyst S. Ganoria now forecasts that the company will post earnings per share of $2.98 for the quarter, doMay 30 at 1:30 AM | americanbankingnews.comAbbVie Inc. Expected to Earn Q2 2025 Earnings of $2.98 Per Share (NYSE:ABBV)May 29 at 11:55 PM | marketbeat.comCatalytic Wealth RIA LLC Makes New $1.44 Million Investment in AbbVie Inc. (NYSE:ABBV)Catalytic Wealth RIA LLC bought a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 9,276 shares of the company's stock, valued at approximately $1,438,000. Several other institutional inveMay 29 at 5:47 PM | msn.comAbbVie shares fell for seven straight daysMay 29 at 5:47 PM | seekingalpha.comLooking For Both Income And Growth? 4%-Yielding AbbVie Has You CoveredMay 29 at 5:47 PM | finance.yahoo.comAre Options Traders Betting on a Big Move in AbbVie (ABBV) Stock?May 29 at 2:30 PM | marketbeat.comAbbVie (NYSE:ABBV) Shares Down 0.4% AbbVie (NYSE:ABBV) Trading Down 0.4%May 29 at 1:04 PM | businesswire.comCalling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your LossesMay 29 at 6:20 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Forecasted to Post Q2 2025 Earnings of $2.98 Per ShareAbbVie Inc. (NYSE:ABBV - Free Report) - Investment analysts at Zacks Research increased their Q2 2025 earnings per share estimates for AbbVie in a report issued on Monday, May 27th. Zacks Research analyst S. Ganoria now forecasts that the company will earn $2.98 per share for the quarter, up fromMay 29 at 12:50 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Position Lessened by Bruce & Co. Inc.Bruce & Co. Inc. trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 15.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 138,000 shares of the company's stock after sMay 28, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Stock Price Down 0.9%AbbVie (NYSE:ABBV) Trading Down 0.9%May 28, 2024 | prnewswire.comAbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024 with New Data from Its Innovative Antibody-Drug Conjugate (ADC) PlatformMay 28, 2024 | marketbeat.comPine Valley Investments Ltd Liability Co Acquires 4,850 Shares of AbbVie Inc. (NYSE:ABBV)Pine Valley Investments Ltd Liability Co boosted its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 10.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,330 shares of the company's stMay 27, 2024 | msn.comDown 14% from All-Time Highs, is This Dividend King a Buy on the Dip?May 27, 2024 | investorplace.com7 Biotech Stocks to Put on Your Breakthrough RadarMay 27, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Stock Price Down 0.8%AbbVie (NYSE:ABBV) Trading Down 0.8%May 26, 2024 | marketbeat.comMUFG Securities EMEA plc Takes Position in AbbVie Inc. (NYSE:ABBV)MUFG Securities EMEA plc acquired a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 140,000 shares of the company's stock, valued at approximately $21,696,000. AbbVie maMay 26, 2024 | fool.comForget Nvidia, Buy This Magnificent Healthcare Stock InsteadMay 25, 2024 | americanbankingnews.comAbbVie (NYSE:ABBV) Shares Down 0.1% May 25, 2024 | fool.comWant Decades of Passive Income? 3 Stocks to Buy Now and Hold ForeverMay 25, 2024 | marketbeat.com839,739 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Westfield Capital Management Co. LPWestfield Capital Management Co. LP purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 839,739 shares of the company's stock, valued at approximately $130,134,000. AbMay 24, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Stock Price Down 0.4%AbbVie (NYSE:ABBV) Trading Down 0.4%May 24, 2024 | stockhouse.comCerevel's Merger with AbbVie for $45 Per Share Leads to Investigation - Contact BFA Law to Discuss How this Impacts YouMay 23, 2024 | marketbeat.comTeam Hewins LLC Acquires New Shares in AbbVie Inc. (NYSE:ABBV)Team Hewins LLC acquired a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 9,090 shares of the company's stock, valued at approximately $1,409,000. A number of other hedge funds havMay 23, 2024 | prnewswire.comAbbVie Completes Acquisition of Landos BiopharmaMay 23, 2024 | investorplace.com3 Biotech Stocks to Buy on the Dip: May 2024May 22, 2024 | marketbeat.comWBI Investments LLC Purchases Shares of 10,958 AbbVie Inc. (NYSE:ABBV)WBI Investments LLC purchased a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 10,958 shares of the company's stock, valued at approxiMay 22, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Trading Down 1.9%AbbVie (NYSE:ABBV) Shares Down 1.9%May 22, 2024 | finance.yahoo.comBaseLaunch announces a new partnership with AbbVieMay 22, 2024 | finance.yahoo.comAdd These Dividend Stocks To Your Portfolio To Boost Your Retirement Income, Plus 2 High-Yield AlternativesMay 22, 2024 | fool.comA Must-Own Stock for Any PortfolioMay 22, 2024 | businesswire.comAlzamend Neuro Announces Favorable Decision from Nasdaq Hearings PanelMay 22, 2024 | fool.com2 Billion More Reasons to Buy AbbVie StockMay 22, 2024 | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by CENTRAL TRUST CoCENTRAL TRUST Co lessened its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 3.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 239,800 shares of the company's stock after selling 8,229 shares duriMay 21, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Stock Price Down 1%AbbVie (NYSE:ABBV) Trading Down 1%May 20, 2024 | marketbeat.comFranklin Resources Inc. Grows Stock Position in AbbVie Inc. (NYSE:ABBV)Franklin Resources Inc. increased its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 4.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,570,685 shares of the company's stock after purchasing an additional 338,789 sharMay 20, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Trading Down 0.3%AbbVie (NYSE:ABBV) Shares Down 0.3%May 20, 2024 | investorplace.com3 S&P 500 Stocks That Have Proven Themselves Recession-Proof Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election. See who it is HERE. ABBV Media Mentions By Week ABBV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼0.510.79▲Average Medical News Sentiment ABBV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼3724▲ABBV Articles Average Week Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AMGN News Today GILD News Today MRNA News Today SGEN News Today IDXX News Today IQV News Today BNTX News Today ILMN News Today JANX News Today LLY News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABBV) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
